Clinical Trial Update: Metastasis-directed Therapy for Oligorecurrent Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating metastasis-directed therapy for oligorecurrent/prostate cancer; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Prostate Cancer, Prostate Cancer Recurrent | Phase 3 | Status: RECRUITING